Trial 143: Potential probiotic Kluyveromyces marxianus fragilis B0399 modulates the immune response in Caco-2 cells and PBMCs and impacts on the human gut microbiota in an in vitro colonic model syste
Trial 210. RETROSPECTIVE OBSERVATIONAL STUDY TO INVESTIGATE SINERGA, A MULTIFACTORIAL NUTRITIONAL PRODUCT, AND BACTERIAL EXTRACTS IN THE PREVENTION OF RECURRENT RESPIRATORY INFECTIONS IN CHILDREN
INT
Trial 75:The study involved ten patients with atopic dermatitis who were administered particular strains of lactic yeasts. At the end of the study the patients treated with KLUYVER B0399 (Kluyveromyce
